Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to 0.4.

  • Vanda Pharmaceuticals' Asset Utilization Ratio rose 2978.72% to 0.4 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.4, marking a year-over-year increase of 2978.72%. This contributed to the annual value of 0.38 for FY2025, which is 2386.23% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Asset Utilization Ratio of 0.4 as of Q4 2025, which was up 2978.72% from 0.35 recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Asset Utilization Ratio peaked at 0.47 during Q1 2021, and registered a low of 0.27 during Q1 2024.
  • Its 5-year average for Asset Utilization Ratio is 0.37, with a median of 0.38 in 2023.
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Asset Utilization Ratio tumbled by 3199.75% in 2024, and later surged by 2978.72% in 2025.
  • Vanda Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.46 in 2021, then decreased by 11.54% to 0.41 in 2022, then dropped by 26.27% to 0.3 in 2023, then rose by 2.29% to 0.31 in 2024, then increased by 29.79% to 0.4 in 2025.
  • Its last three reported values are 0.4 in Q4 2025, 0.35 for Q3 2025, and 0.32 during Q2 2025.